Application 021430
- Type
- NDA
- Sponsor
- CELGENE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | THALOMID | THALIDOMIDE | CAPSULE; ORAL | 50MG | No | No |
| 002 | THALOMID | THALIDOMIDE | CAPSULE; ORAL | 100MG | No | No |
| 003 | THALOMID | THALIDOMIDE | CAPSULE; ORAL | 200MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Thalomid | THALIDOMIDE | Celgene Corporation | 2eda833b-1357-4ed4-a093-194524fcb061 | 2023-03-24 | Boxed warning, Warnings, Adverse reactions | Thalomid THALIDOMIDE |